1-800-625-3837 1-800-625-3837 $300.00 BPC-157 Injectable 3mg/mL (5mL Vial) BPC-157 is a synthetic peptide clinically studied for its regenerative effects
The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing
A subcutaneous (SC) injection takes a slightly different approach
Search Peptide Dosage Guides Search 100+ research peptides for vial size, BAC water, dosing, frequency, and cycle length for 100+ research peptides, including BPC-157, TB-500, Semaglutide, and Retatrutide
Ongoing phase 3 trials are in progress, and CagriSema is currently under FDA review, with a decision expected in late 2026
Researchers commonly choose bacteriostatic water for peptide reconstitution because it contains 0.9% benzyl alcohol, which helps inhibit bacterial growth during repeated withdrawals from the same vial
